SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000944809-23-000008
Filing Date
2023-02-10
Accepted
2023-02-10 16:48:56
Documents
12
Period of Report
2023-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K opk-20230210.htm   iXBRL 8-K 37610
  Complete submission text file 0000944809-23-000008.txt   174135

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20230210.xsd EX-101.SCH 1929
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20230210_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20230210_pre.xml EX-101.PRE 12538
6 EXTRACTED XBRL INSTANCE DOCUMENT opk-20230210_htm.xml XML 10812
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 23612904
SIC: 2834 Pharmaceutical Preparations